marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Inovio Pharmaceuticals Cash Flow 2011-2024 | INO
Annual Cash Flow Inovio Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-124 M | -216 M | -216 M | -178 M | -97.9 M | -73.6 M | -63.2 M | -62.6 M | -12.4 M | -29.8 M | -15.4 M | -22.3 M | -19.8 M |
Depreciation & Amortization |
2.62 M | 3.66 M | 3.04 M | 3.04 M | 3.6 M | 3.75 M | 1.85 M | 1.71 M | 1.05 M | 627 K | 329 K | 174 K | 142 K |
Accounts Payables |
- | - | - | - | - | - | 23.3 M | 19.6 M | 13.1 M | 6.38 M | 5.44 M | 3.18 M | - |
Accounts Receivables |
- | - | - | 18.6 M | 700 K | 3.32 M | 6 M | 15.8 M | 7.33 M | 2.8 M | 3.3 M | 830 K | 468 K |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Inovio Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -28.8 M | - | - | - | -36.7 M | - | -180 M | -112 M | -61.9 M | - | -178 M | -131 M | -52.9 M | - | -127 M | -52.6 M | -25.5 M | - | -84.1 M | -56.4 M | -32.5 M | - | -56.3 M | -31.6 M | -12.6 M | - | -49.3 M | -31.9 M | -15.2 M | - | -47.7 M | -29 M | -15.7 M | - | -5.66 M | -21.1 M | -12.1 M | - | -21.7 M | -13.7 M | -5.56 M | - | -16.3 M | -10.6 M | -5.13 M | - | -16.8 M | -10.8 M | -5.44 M | - | -15.2 M | -9.96 M | -5.5 M |
Depreciation & Amortization |
- | - | 424 K | - | - | - | 707 K | - | 2.78 M | 1.87 M | 929 K | - | 2.09 M | 1.36 M | 661 K | - | 2.32 M | 1.61 M | 810 K | - | 2.75 M | 1.86 M | 931 K | - | 2.77 M | 1.84 M | 898 K | - | 1.78 M | 1.02 M | 522 K | - | 1.29 M | 827 K | 388 K | - | 734 K | 451 K | 214 K | - | 429 K | 244 K | 116 K | - | 125 K | 81 K | 39.8 K | - | 124 K | 77.2 K | 36.8 K | - | 102 K | 66.6 K | 32.3 K |
Accounts Payables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 23.1 M | - | - | - | 23.3 M | - | - | - | 19.6 M | - | - | - | 13.1 M | - | - | - | 6.38 M | - | - | - | 5.44 M | - | - | - | 3.18 M | - | - | - | 4.32 M | - | - | - |
Accounts Receivables |
1.86 M | 1.77 M | 2.55 M | 2.41 M | - | - | 73.3 K | 1.7 M | 2.44 M | 4.48 M | 4 M | 5.47 M | 4.77 M | 13.1 M | 9.91 M | 18.6 M | 18.6 M | 18.6 M | 18.6 M | 700 K | 700 K | 700 K | 700 K | 3.32 M | 3.32 M | 3.32 M | 3.32 M | 6 M | 6 M | 6 M | 6 M | 15.8 M | 15.8 M | 15.8 M | 15.8 M | 7.3 M | 7.33 M | 7.33 M | 7.33 M | 2.8 M | 2.8 M | 2.8 M | 2.8 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 830 K | 830 K | 830 K | 830 K | 468 K | 468 K | 468 K | 468 K |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency